Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus.

作者: Marilia Brito Gomes , Roberta Arnold Cobas , Edson Nunes , Hugo Caire Castro-Faria-Neto , Maria Fátima Bevilacqua da Matta

DOI: 10.1016/J.DIABRES.2009.04.016

关键词:

摘要: Abstract Aims We evaluated if type 1 diabetic patients have altered levels of low-grade inflammatory markers including platelet-activating factor acetylhydrolase (PAF-AH) activity, high-sensitivity C-reactive protein (hs-CRP), white blood cells count (WBC), erythrocyte sedimentation rate (ESR) and LDL-cholesterol oxidation coefficient (OxC), whether their are related to clinical complications the metabolic profile. Methods studied cross-sectionally 118 outpatients with diabetes both (n = 38) without (n = 80) chronic complications, 110 controls subjects. Results Diabetic had higher PAF-AH activity (p = 0.02), hs-CRP (p = 0.001), WBC (p = 0.004) ESR (p = 0.0001) than controls. Patients earlier OxC non-diabetic subjects at 3 h (p = 0.01) after addition CuSO4. No difference was noted between complications. In patients, correlations were found 3 h. Conclusions It concluded that susceptibility LDL in vitro inflammation increased each other. The presence these is probably independent reveals development early pro-inflammatory state.

参考文章(58)
Shahar Lavi, Ronit Lavi, Joseph P. McConnell, Lilach O. Lerman, Amir Lerman, Lipoprotein-Associated Phospholipase A2 Review of its Role as a Marker and a Potential Participant in Coronary Endothelial Dysfunction Molecular Diagnosis & Therapy. ,vol. 11, pp. 219- 226 ,(2007) , 10.1007/BF03256243
Anton J. AARSMAN, Fred W. NEYS, Henk BOSCH, Catabolism of platelet-activating factor and its acyl analog FEBS Journal. ,vol. 200, pp. 187- 193 ,(1991) , 10.1111/J.1432-1033.1991.TB21066.X
Adriana R. Silva, Edson F. de Assis, Lara F. C. Caiado, Gopal K. Marathe, Marcelo T. Bozza, Thomas M. McIntyre, Guy A. Zimmerman, Stephen M. Prescott, Patricia T. Bozza, Hugo C. Castro-Faria-Neto, Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. Journal of Immunology. ,vol. 168, pp. 4112- 4120 ,(2002) , 10.4049/JIMMUNOL.168.8.4112
D.M. Stafforini, S.M. Prescott, T.M. McIntyre, Human plasma platelet-activating factor acetylhydrolase. Purification and properties. Journal of Biological Chemistry. ,vol. 262, pp. 4223- 4230 ,(1987) , 10.1016/S0021-9258(18)61336-5
Simone H. de Castro, Hugo C. Castro-Faria-Neto, Marilia B. Gomes, Association of Postprandial Hyperglycemia with in Vitro LDL Oxidation in Non-Smoking Patients with Type 1 Diabetes – a Cross-Sectional Study The review of diabetic studies : RDS. ,vol. 2, pp. 157- 164 ,(2005) , 10.1900/RDS.2005.2.157
Diabetes Control and Complications Trial, None, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. The New England Journal of Medicine. ,vol. 353, pp. 2643- 2653 ,(2005) , 10.1056/NEJMOA052187
Marilia de Brito Gomes, Roberta Arnold Cobas, Edson Nunes, Michele Nery, Hugo Caire Castro-Faria-Neto, Eduardo Tibiriçá, Serum platelet-activating factor acetylhydrolase activity: a novel potential inflammatory marker in type 1 diabetes. Prostaglandins & Other Lipid Mediators. ,vol. 87, pp. 42- 46 ,(2008) , 10.1016/J.PROSTAGLANDINS.2008.07.001
Makoto Mark Taketo, Masahiro Sonoshita, Phospolipase A2 and apoptosis. Biochimica et Biophysica Acta. ,vol. 1585, pp. 72- 76 ,(2002) , 10.1016/S1388-1981(02)00326-8
Debra A Schaumberg, Robert J Glynn, Alicia J Jenkins, Timothy J Lyons, Nader Rifai, JoAnn E Manson, Paul M Ridker, David M Nathan, None, Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial Circulation. ,vol. 111, pp. 2446- 2453 ,(2005) , 10.1161/01.CIR.0000165064.31505.3B
Hermann Esterbauer, Janusz Gebicki, Herbert Puhl, Günther Jürgens, The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biology and Medicine. ,vol. 13, pp. 341- 390 ,(1992) , 10.1016/0891-5849(92)90181-F